Biosante Pharmaceuticals shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Biosante Pharmaceuticals (ANIP) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Biosante Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Biosante Pharmaceuticals held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Biosante Pharmaceuticals by MetLife Investment Advisors
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $423k | 7.7k | 55.14 |
2023-09-30 | $446k | 7.7k | 58.06 |
2023-06-30 | $362k | 6.7k | 53.83 |
2023-03-31 | $267k | 6.7k | 39.72 |
2022-12-31 | $259k | 6.4k | 40.23 |
2022-09-30 | $188k | 5.9k | 32.09 |
2022-06-30 | $174k | 5.9k | 29.70 |
2022-03-31 | $165k | 5.9k | 28.17 |
2021-12-31 | $172k | 3.7k | 46.10 |
2021-09-30 | $123k | 3.7k | 32.82 |
2020-12-31 | $115k | 3.9k | 29.04 |
2020-09-30 | $111k | 3.9k | 28.21 |
2020-06-30 | $128k | 3.9k | 32.45 |
2020-03-31 | $161k | 3.9k | 40.81 |
2019-12-31 | $243k | 3.9k | 61.67 |
2019-09-30 | $288k | 3.9k | 73.00 |
2019-06-30 | $324k | 3.9k | 82.13 |
2019-03-31 | $278k | 3.9k | 70.54 |
2018-12-31 | $178k | 3.9k | 45.12 |
2018-09-30 | $347k | 6.1k | 56.51 |
2018-06-30 | $264k | 3.9k | 66.92 |
2018-03-31 | $230k | 3.9k | 58.30 |
2017-12-31 | $254k | 3.9k | 64.39 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors